Home Biosimilar Antibodies Others Others antibody Demcizumab (Anti-DLL4) For research use only.
Not for use in humans.

Demcizumab (Anti-DLL4)

Synonyms: OMP 21M18; Human Anti-TNFRSF10B Recombinant Antibody

Demcizumab (Anti-DLL4) is a monoclonal antibody taregting DLL4. Demcizumab is a potent inhibitor of the Notch pathway. Demcizumab alone or in combination with chemotherapy is effective in various cancer models. MW: 145.5 KD.

Demcizumab (Anti-DLL4)

Purity & Quality Control

≥99

Biological Activity

Description Demcizumab (Anti-DLL4) is a monoclonal antibody taregting DLL4. Demcizumab is a potent inhibitor of the Notch pathway. Demcizumab alone or in combination with chemotherapy is effective in various cancer models. MW: 145.5 KD.

Product Details

CAS No. 1243262-17-0
Molecular Weight 145.5 kDa
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Demcizumab (Anti-DLL4) | Demcizumab (Anti-DLL4) supplier | purchase Demcizumab (Anti-DLL4) | Demcizumab (Anti-DLL4) cost | Demcizumab (Anti-DLL4) manufacturer | order Demcizumab (Anti-DLL4) | Demcizumab (Anti-DLL4) distributor